After a median of 4-5 years in untreated patients, there is a transition from chronic phase CML to an accelerated phase or blast crisis. The accelerated phase is a transitional period that is ...
In March 2025, Akeso initiated an open-label, Phase Ib/II study involving patients diagnosed with acute myeloid leukemia (AML ...
The cancer develops from myeloid blasts cells that would normally turn into white blood cells. Acute myeloid leukemia (AML) is one of the most common types of leukaemia among adults.
Actinium Pharmaceuticals (ATNM) announced that the first clinical trial under its previously announced Cooperative Research and Development ...
Chronic myeloid leukemia (CML) is characterized by the formation of the Philadelphia chromosome and oncogenic signaling by the resulting Bcr-Abl fusion protein. Understanding the molecular basis ...
the myeloid cells start multiplying rapidly due to DNA modifications. The rapid production also results in the formation of immature or abnormal cells called blasts that cannot function properly.
Scientists have identified an innovative combination of treatment strategies that work collaboratively to effectively kill acute myeloid leukemia (AML) cells, a frequently incurable form of cancer.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback